• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Cytori Therapeutics, Inc. (CYTX)

    -NasdaqCM
    2.02 Up 0.02(1.00%) Jun 24, 4:00PM EDT
    Prev Close:2.00
    Open:1.95
    Bid:N/A
    Ask:2.14 x 2000
    1y Target Est:9.25
    Beta:3.10729
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:1.91 - 2.03
    52wk Range:1.91 - 9.15
    Volume:182,386
    Avg Vol (3m):211,397
    Market Cap:40.48M
    P/E (ttm):N/A
    EPS (ttm):-0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTX

    Comparison

    Symbol% ChgMkt Cap
    CYTXUp 1.00%40.48M
    BAXDown 4.59%24.22B
    OSIRDown 5.82%178.47M
    ASTM 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.78
    Quarterly EPS Est (Jun-16) :-0.47
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback